Point of Care Ultrasound (POCUS) Market Analysis

Point of Care Ultrasound (POCUS) Market Analysis

The diagnostics devices segment in the point of care ultrasound market is projected to generate over USD 4 billion by 2032. The growing frequency of chronic illnesses has increased the demand for ultrasonic imaging for the diagnosis of diseases owing to its cost-effectiveness compared to other medical imaging technologies. Additionally, several industry leaders are launching initiatives to offer ultrasound services. For instance, in September 2022, the Philips Foundation and RAD-AID International signed a multi-year cross-continental collaboration to provide ultrasound services to 50 million patients in low- and middle-income nations.
 

Trolley-based point of care ultrasound market is estimated to record 6.2% CAGR till 2032 driven by the increasing adoption of trolley-based devices in emergency care rooms. The rising advancements in technology have made way for more compact and portable trolley-based ultrasound systems to offer enhanced accessibility and usability in various healthcare settings. Furthermore, the growing awareness among healthcare professionals about the benefits of point-of-care ultrasound is promoting early diagnosis and intervention.
 

Point of care ultrasound market from the urology segment accounted for over USD 414 million in 2022 driven by the increasing product demand in urology clinics and emergency rooms due to the rising prevalence of urological disorders, including kidney stones, urinary tract infections, and prostate abnormalities. Urologists increasingly rely on ultrasound for non-invasive and real-time imaging of the urinary tract and reproductive organs.  Technological advancements in the field of urology POC ultrasound has resulted in the availability of more efficient devices.
 

North America point of care ultrasound market held 33.6% share in 2022 and is estimated to be worth USD 2.3 billion by 2032. The high patient population suffering from chronic illnesses is responsible for this significant regional market share. According to the National Association of Chronic Disease Directors' 2022 report, approximately 60% of adult Americans suffer from at least one chronic condition.  Furthermore, the strong presence of important industrial players together with the rising usage of new technologies.